BioHealth News
IonQ Speeds Quantum-Accelerated Drug Development Application With AstraZeneca, AWS, and NVIDIA
COLLEGE PARK, Md.--(BUSINESS WIRE)--IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, announced results of a collaborative research program between IonQ, AstraZeneca,…
Read More
Previous BHCR Crab Trap Winner Luminoah Selected for Prestigious MedTech Innovator 2025 Accelerator Cohort
Charlottesville, VA – June 5, 2025 – Luminoah, a medical device company transforming chronic disease care through personalized enteral nutrition delivery, announced today that it…
Read More
GlycoMimetics Stockholders Approve Proposed Merger with Crescent Biopharma and All Related Proposals
ROCKVILLE, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc. (Nasdaq: GLYC) (“GlycoMimetics”) today announced that its stockholders have approved the proposed merger (the “Merger”) with Crescent Biopharma, Inc. (“Crescent”),…
Read More
REGENXBIO Shares Promising Early Results from Gene Therapy Trial for Duchenne Muscular Dystrophy
ROCKVILLE, Md., June 5, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced new positive interim data from the Phase I/II AFFINITY DUCHENNE trial. Updates include positive functional,…
Read More
Decoding Federal Dollars: Grant Engine CEO Sam Tetlow on the Evolving Biohealth Funding Map on BioTalk
In this episode of BioTalk, Sam Tetlow, Founder and CEO of Grant Engine, joins the conversation to share insights on how early-stage biotech and…
Read More
USP announces new Advanced Technologies Laboratory in Maryland to accelerate and scale pharmaceutical manufacturing innovations
Lab will help enable broader adoption of advanced manufacturing technologies and state-of-the-art quality solutions Rockville, MD - June 4, 2025 - The U.S. Pharmacopeia (USP)…
Read More
Welldoc Works with Lilly to Launch a New Personalized Health & Medicine Platform for Those Prescribed Lilly’s Incretin Therapies
COLUMBIA, Md., June 4, 2025 — Welldoc®, a leader in AI-powered digital health innovation, today announced it will power the newly launched Lilly Health™ Personalized…
Read More
Maryland Stem Cell Research Fund Announces Call for Applications for the July 2025 Cycle
COLUMBIA, Md., June 4, 2025 /PRNewswire/ -- The Maryland Stem Cell Research Commission ("Commission") is pleased to announce the release of Requests for Applications (RFAs) for…
Read More
IonQ Completes Acquisition of Lightsynq, Accelerating Quantum Computing and Networking Roadmap
COLLEGE PARK, MD – June 3, 2025 - IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, today announced the successful completion of…
Read More
CoapTech Raises New Funding Round Led by Good Growth Capital
Baltimore, Md. (May 28, 2025) – CoapTech Inc., a Baltimore-based medical device company, announced today the initial close of a Series B funding round, which…
Read More
Danaher Announces Diagnostic Development and Commercialization Partnership to Scale Precision Medicine
WASHINGTON, May 29, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher"), a global science and technology innovator, announced today the launch of a partnership with AstraZeneca (LSE/STO/Nasdaq:…
Read More
Bizjournals: Virginia Tech seeks industry partners for Institute for Advanced Computing
By Nate Doughty – Staff Reporter, Washington Business Journal - Virginia Tech this week unveiled the Institute for Advanced Computing at its Potomac Yard campus…
Read More
Virginia Business: GO Virginia grant boosts biotech in Roanoke, New River Valley
Ralph Berrier Jr. //June 1, 2025// - A $4.9 million grant from the commonwealth will allow leaders from the Roanoke and New River valleys to build upon…
Read More
Banking with Heart: Rick Wieczorek on Financial Solutions for the Biohealth Community on BioTalk
In this episode of BioTalk, we welcome Rick Wieczorek, President and CEO of the NIH Federal Credit Union (NIHFCU), to discuss how credit unions like…
Read More
Cartesian Therapeutics Announces First Participant Enrolled in Phase 3 Trial of Descartes-08 for Myasthenia Gravis
FREDERICK, Md., May 30, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (“Cartesian” or the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today…
Read More